GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (XCNQ:GLAB) » Definitions » Total Equity

Gemina Laboratories (XCNQ:GLAB) Total Equity : C$-1.59 Mil (As of Jan. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Gemina Laboratories Total Equity?

Gemina Laboratories's total equity for the quarter that ended in Jan. 2024 was C$-1.59 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Gemina Laboratories Total Equity Historical Data

The historical data trend for Gemina Laboratories's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gemina Laboratories Total Equity Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24
Total Equity
0.16 0.94 -0.07 -1.59

Gemina Laboratories Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.07 1.49 0.10 -0.67 -1.59

Gemina Laboratories Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Gemina Laboratories's Total Equity for the fiscal year that ended in Jan. 2024 is calculated as

Total Equity=Total Assets(Q: Jan. 2024 )-Total Liabilities(Q: Jan. 2024 )
=1.456-3.041
=-1.59

Gemina Laboratories's Total Equity for the quarter that ended in Jan. 2024 is calculated as

Total Equity=Total Assets(Q: Jan. 2024 )-Total Liabilities(Q: Jan. 2024 )
=1.456-3.041
=-1.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gemina Laboratories Total Equity Related Terms

Thank you for viewing the detailed overview of Gemina Laboratories's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Gemina Laboratories (XCNQ:GLAB) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (XCNQ:GLAB) » Definitions » Total Equity
Comparable Companies
TSX:ATE TSXV:GSD TSX:MBX TSX:TH TSXV:TTI XCNQ:ACOG TSXV:MSCL TSXV:COV TSX:APS TSXV:CZO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
GLABF:USA 8I7:Germany
Address
3800 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Website
https://www.geminalabs.com
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.
Executives
James Damian Tansey Director

Gemina Laboratories (XCNQ:GLAB) Headlines

No Headlines